Telomir Pharmaceuticals Inc (TELO)

Nov 28, 2025

Telomir Pharmaceuticals announces new preclinical data on Telomir-1 - MSN

Nov 28, 2025

Nov 27, 2025

Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - MarketScreener

Nov 27, 2025

Nov 26, 2025

Telomir Pharmaceuticals Unveils Promising Preclinical Cancer Data - MSN

Nov 26, 2025

Nov 25, 2025

Telomir reports PSA reduction in prostate cancer cells with lead drug - Investing.com India

Nov 25, 2025

Nov 25, 2025

Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Significantly Reduces PSA Levels in Human Prostate Cancer Cells - The Joplin Globe

Nov 25, 2025

Nov 24, 2025

Telomir Pharmaceuticals Reports Promising Preclinical Data - TipRanks

Nov 24, 2025

Nov 24, 2025

[8-K] Telomir Pharmaceuticals, Inc. Reports Material Event | TELO SEC FilingForm 8-K - Stock Titan

Nov 24, 2025

Nov 23, 2025

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells - Bluffton Today

Nov 23, 2025

Nov 23, 2025

TELO Stock Jumps Pre-market After Early Study Results Show Leukemia Cell Death - MSN

Nov 23, 2025

Nov 21, 2025

Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Will Telomir Pharmaceuticals Bounce Back? - StocksToTrade

Nov 21, 2025

Nov 21, 2025

Telomir Pharmaceuticals (TELO) Unveils Leukemia Breakthrough and Board Change – Full Investor Update for November 21, 2025 - ts2.tech

Nov 21, 2025

Nov 21, 2025

Telomir stock surges after leukemia cell-killing data By Investing.com - Investing.com Nigeria

Nov 21, 2025

Nov 21, 2025

Telomir stock surges after leukemia cell-killing data - Investing.com UK

Nov 21, 2025

Nov 21, 2025

Telomir Pharma (NASDAQ: TELO) Telomir-1 Shows Preclinical HL60 Leukemia Activity - Stock Titan

Nov 21, 2025

Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board By Investing.com - Investing.com Australia

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals director Craig Eagle resigns from board - Investing.com

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals Inc. Announces Resignation of Craig Eagle as Director, Effective on November 14, 2025 - MarketScreener

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals’ Telomir-1 Shows Leukemia Efficacy - TipRanks

Nov 20, 2025

Nov 20, 2025

Telomir Pharmaceuticals, Inc. Announces Telomir-1 Kills Aggressive Human Leukemia Cells - MarketScreener

Nov 20, 2025

Nov 20, 2025

How Telomir Pharmaceuticals Inc. stock performs after earnings2025 Market Overview & Precise Buy Zone Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Does Telomir Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Summary & Daily Stock Trend Watchlist - newser.com

Nov 20, 2025

Nov 19, 2025

Will Telomir Pharmaceuticals Inc. bounce back from current supportMarket Activity Recap & Precise Buy Zone Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - newser.com

Nov 19, 2025

Nov 19, 2025

Telomir Pharmaceuticals Completes $2.9 Million Stock Sale - MSN

Nov 19, 2025

Nov 19, 2025

Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com

Nov 19, 2025

Nov 17, 2025

What technical models suggest about Telomir Pharmaceuticals Inc.’s comebackFed Meeting & Daily Oversold Bounce Ideas - newser.com

Nov 17, 2025

Nov 16, 2025

What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Sell Signal & High Win Rate Trade Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Will Telomir Pharmaceuticals Inc. rebound enough to break even2025 Retail Activity & Reliable Trade Execution Plans - newser.com

Nov 16, 2025